Stage-Related Alterations in Renal Cell Carcinoma – Comprehensive Quantitative Analysis by 2D-DIGE and Protein Network Analysis

S100A8/A9 Activate Key Genes and Pathways in Colon Tumor Progression

(2011) M. Ichikawa et al.   MOLECULAR CANCER RESEARCH

Combined Blood/Tissue Analysis for Cancer Biomarker Discovery: Application to Renal Cell Carcinoma

(2010) Donald J. Johann et al.   ANALYTICAL CHEMISTRY

Molecular Markers Implicating Early Malignant Events in Cervical Carcinogenesis

(2010) H.-M. Koskimaa et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Comparative proteomic analysis identifies proteins associated with the development and progression of colorectal carcinoma

(2010) Liang Zhao et al.   FEBS Journal

Peroxiredoxin III protects pancreatic β cells from apoptosis

(2010) Gabriele Wolf et al.   JOURNAL OF ENDOCRINOLOGY

Panel of Candidate Biomarkers for Renal Cell Carcinoma

(2010) Dong Su Kim et al.   JOURNAL OF PROTEOME RESEARCH

Gastric Cancer-Specific Protein Profile Identified Using Endoscopic Biopsy Samples via MALDI Mass Spectrometry

(2010) Hark Kyun Kim et al.   JOURNAL OF PROTEOME RESEARCH

Prohibitins Are Required for Cancer Cell Proliferation and Adhesion

(2010) Claudia Sievers et al.   PLoS One

Prohibitin deficiency blocks proliferation and induces apoptosis in human hepatoma cells: Molecular mechanisms and functional implications

(2010) Virginia Sánchez-Quiles et al.   PROTEOMICS

Insulin induced phosphorylation of prohibitin at tyrosine114 recruits Shp1

(2009) Sudharsana R. Ande et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo

(2009) Ramon C. Sun et al.   BREAST CANCER RESEARCH AND TREATMENT

Peroxiredoxins, a novel target in cancer radiotherapy

(2009) Bo Zhang et al.   CANCER LETTERS

S100A8/A9: A Janus-faced molecule in cancer therapy and tumorgenesis

(2009) Saeid Ghavami et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Differential Protein Expressions in Renal Cell Carcinoma: New Biomarker Discovery by Mass Spectrometry

(2009) K. W. Michael Siu et al.   JOURNAL OF PROTEOME RESEARCH

Renal cell carcinoma

(2009) Brian I Rini et al.   LANCET

Systematic Comparative Protein Expression Profiling of Clear Cell Renal Cell Carcinoma

(2009) Rudolf Lichtenfels et al.   MOLECULAR & CELLULAR PROTEOMICS

Interaction between O-GlcNAc Modification and Tyrosine Phosphorylation of Prohibitin: Implication for a Novel Binary Switch

(2009) Sudharsana R. Ande et al.   PLoS One

Combined analysis of transcriptome and proteome data as a tool for the identification of candidate biomarkers in renal cell carcinoma

(2009) Barbara Seliger et al.   PROTEOMICS

S100A8 and S100A9 Overexpression Is Associated with Poor Pathological Parameters in Invasive Ductal Carcinoma of the Breast

(2008) Kazumori Arai et al.   CURRENT CANCER DRUG TARGETS

Targeting energy metabolism in brain cancer with calorically restricted ketogenic diets

(2008) Thomas N. Seyfried et al.   EPILEPSIA

Prohibitin silencing reverses stabilization of mitochondrial integrity and chemoresistance in ovarian cancer cells by increasing their sensitivity to apoptosis

(2008) Rosalind C. Gregory-Bass et al.   INTERNATIONAL JOURNAL OF CANCER

Quantitative proteomic analysis to discover potential diagnostic markers and therapeutic targets in human renal cell carcinoma

(2008) Noboru Okamura et al.   PROTEOMICS